12 December 2017 : Original article
A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B
DOI: 10.12659/AOT.905898
Ann Transplant 2017; 22:740-748
HTML version available soon